Flow Cytometry in Oncology and Immunology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Type (Immunology, Oncology), By Technology (Cell-based flow cytometry, Bead-based Flow Cytometry), By Offering (Reagents, Instruments, and Consumables Software), By Application (Translational Research, Clinical Research), By End User (Hospitals, Di

According to the World Health Organization, Cancer is one of the leading cause of disease burden and mortality in the world, and strategies for cancer prevention, diagnosis, and treatment are still a global effort.

Rising Prevalence of Cancer Cases

Globally, Cancer is one of the prevalent causes of death.The global increase in cancer cases is probably a factor in the oncology molecular diagnostics market's expansion. In the United States of America in 2021, there were 1.8 million new cases and 0.6 million cancer deaths, according to the American Cancer Society.

According to Food and Drug Administration (FDA), the multiple clinical trials with successful implementation of immunology and oncology treatments are being conducted to evaluate the efficacy of treatments of multiple cancer types, to implement combinatorial therapies, to gain mechanistic insight for new drug development or to identify immune predictors of clinical response.

Advancement in Technology

Recent Developments & Product Launches

For instance, in June 2022, Becton, Dickinson and Company launched its new cell sorting technology at the International Society for Advancement of Cytometry (ISAC).

Download Free Sample Report

Market Segmentation

Global Flow Cytometry in Oncology and Immunology Market can be segmented by type, technology, offering, application, end user, region, and company. Based on type, the market can be segmented into immunology and oncology. Based on technology, the market is fragmented into cell-based flow cytometry, bead-based flow cytometry. Based on offering, the market is segmented into reagents, instruments, and

Company Profiles

Danaher Corporation, Merck KGaA, Miltenyi Biotec, Neo-Genomics Laboratories, Inc., Thermo Fisher Scientific Inc., Cell Signaling Technology, Inc., Becton, Dickinson and Company, Agilent Technologies, Inc., DiaSorin S.p.A (Luminex Corporation), OPKO Health, Inc. etc. are some of the key players operating in the global flow cytometry in oncology and immunology market.